These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6147658)

  • 1. Nitroglycerin levels after administration via transdermal therapeutic system or as ointment.
    Hirtz J; Imhof PR; Hauser PF
    Lancet; 1984 Sep; 2(8403):633. PubMed ID: 6147658
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment.
    Taylor SH
    Lancet; 1984 Jul; 2(8394):97. PubMed ID: 6146027
    [No Abstract]   [Full Text] [Related]  

  • 3. Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu W
    Lancet; 1984 Jun; 1(8389):1297. PubMed ID: 6145002
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitroglycerin concentration in plasma: comparison between transdermal therapeutic system and ointment.
    Chu LC; Gale RM; Schmitt LG; Shaw JE
    Angiology; 1984 Sep; 35(9):545-52. PubMed ID: 6435484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the safety and efficacy of topical nitroglycerin ointment to facilitate venous cannulation.
    Griffith P; James B; Cropp A
    Nurs Res; 1994; 43(4):203-6. PubMed ID: 8047423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma nitroglycerin concentrations and hemodynamic effects of sublingual, ointment, and controlled-release forms of nitroglycerin.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu WC; Stevens JL
    Clin Pharmacol Ther; 1984 Dec; 36(6):765-72. PubMed ID: 6437723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transcutaneous application of nitroglycerin and isosorbide dinitrate versus placebo: effect in myocardial ischemia].
    Gloor HO; Angehrn W; Steinbrunn W
    Schweiz Med Wochenschr; 1985 Mar; 115(12):412-7. PubMed ID: 3922052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical use of transdermal delivery devices with nitroglycerin.
    Thompson RH
    Angiology; 1983 Jan; 34(1):23-31. PubMed ID: 6401952
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of various cutaneously administered nitroglycerin preparations on coronary heart disease].
    Zeiher A; Drexler H; Bonzel T; Wollschläger H; Hust MH; Löllgen H; Just H
    Schweiz Med Wochenschr Suppl; 1984; 16():70-6. PubMed ID: 6429852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative effectiveness of nitroglycerin ointment according to site of application.
    Hansen MS; Woods SL; Wills RE
    Heart Lung; 1979; 8(4):716-20. PubMed ID: 110729
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma nitroglycerin levels, blood pressure and apical heart rate variations to site of application of nitroglycerin ointment.
    Conant CC
    Nurse Pract; 1988 Oct; 13(10):56, 58, 63-4. PubMed ID: 3147433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal nitroglycerin ointment and patches.
    Todd B
    Geriatr Nurs; 1986; 7(3):152-4. PubMed ID: 3084347
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical nitroglycerin for ischemic heart disease.
    Miner JA; Conti R
    JAMA; 1978 May; 239(20):2166-7. PubMed ID: 417196
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches.
    Chien YW
    Am Heart J; 1984 Jul; 108(1):207-16. PubMed ID: 6428207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of nitroglycerin generated by three nitroglycerin patch preparations, Nitradisc, Transiderm-Nitro and Nitro-Dur and one ointment formulation, Nitrobid.
    McAllister A; Mosberg H; Settlage JA; Steiner JA
    Br J Clin Pharmacol; 1986 Apr; 21(4):365-9. PubMed ID: 3085698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of nitroglycerin ointments in the rabbit.
    Ritschel WA; Ritschel-Beurlin G; Grummich K
    Arzneimittelforschung; 1980; 30(3):432-5. PubMed ID: 6770874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A symposium: Transdermal nitroglycerin--maximizing therapeutic efficacy. July 26, 1985, New York, New York.
    Am J Cardiol; 1985 Dec; 56(17):1I-53I. PubMed ID: 3934949
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of atenolol and nitroglycerin ointment on exertion tolerance in coronary disease].
    Koenig W; Diehm C
    Dtsch Med Wochenschr; 1983 Nov; 108(47):1798-803. PubMed ID: 6416805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal nitroglycerin.
    Hutchinson L
    N C Med J; 1985 Apr; 46(4):247-50. PubMed ID: 3921857
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomised study comparing systemic transdermal treatment and local application of glyceryl trinitrate ointment in the management of chronic anal fissure.
    Colak T; Ipek T; Urkaya N; Kanik A; Dirlik M
    Eur J Surg Suppl; 2003 Jul; (588):18-22. PubMed ID: 15200038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.